Intellectual Property India Publishes Patent Application for 'Compounds And Methods For Modulating Alpha-Synuclein Expression' Filed by Ionis Pharmaceuticals, Inc.

MUMBAI, India, Oct. 11 -- Intellectual Property India has published a patent application (202547088045 A) filed by Ionis Pharmaceuticals, Inc., Carlsbad, U.S.A., on Sept. 16, for 'compounds and methods for modulating alpha-synuclein expression.'

Inventor(s) include Zhao, Hien, Thuy; Freier, Susan, M.; Wan, W., Brad; Thomas, Antony; Migawa, Michael, T; Seth, Punit, P.; and Fitzsimmons, Bethany.

The application for the patent was published on Oct. 10, under issue no. 41/2025.

According to the abstract released by the Intellectual Property India: "Provided herein are compounds, phannaceutical compositions, and methods of use for reducing the amount or activity of SNCA mRNA in a cell or subject, and in certain instances reducing the amount o...